Skip to content

Clinical trials

Active, not recruiting Pulmonary Arterial Hypertension trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Status: Active, not recruiting Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20161
20172
20181
20191
20202
20212
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion2
Liquidia Technologies, Inc.2
Merck Sharp & Dohme LLC2
The Cleveland Clinic2
United Therapeutics2
Insmed Incorporated1
Medtronic Cardiac Rhythm and Heart Failure1
University of Minnesota1
V-Wave Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension14
Connective Tissue Diseases1
Familial Primary Pulmonary Hypertension1
Inflammation1
Insulin Resistance1
Respiratory Aspiration1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.